Abstract
The COVID-19 pandemic devastated the globe, claimed billions of lives, and hampered trade and regular activities. Safety against the COVID-19 pandemic was the priority of the whole human species in society, the workplace, the family, and personal life. All sectors have been working responsibly to adjust to the new normal. The government is doing its best to implement the best laws and regulations to support and protect livelihood and industry. Healthcare professionals were at risk, and HR employees found it difficult to ensure effective and efficient business operations. The purpose of the study was to examine the role of HR professionals and investigate problems encountered in confronting the COVID-19 pandemic to improve workplace flexibility in the healthcare sector.
The study used an evidence-based technique reproducible from previous research on HR issues in the health industry during the COVID-19 era. Such methodology assisted in producing a wide range of results from within and outside India. The population was selected with the health-related articles published between April 2020 to November 2021 during the COVID-19 era.
The findings showed that redesigning the systems posed the biggest challenge for HR employees and required significant financial commitment, skilled human resources, cutting-edge technology, and an adequate supply of PPE. Thus, the HR managers were tasked with safeguarding a favourable environment by prioritising adequate, efficient, and workplace flexibility.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email ID: ajit.kerketta{at}res.christuniversity.in
Email ID: sathiayseelan.b{at}christuniversity.in
The title of the manuscript was modified. The manuscript's approach was inconsistent in its earlier versions, while the current version strictly adheres to PRISMA guidelines. The figure 1 was updated to PRISMA 2020 flow diagram. The author affiliation was updated.
Data Availability
All data produced in the present work are contained in the manuscript.
